Patent Landscape and Claims Analysis for U.S. Patent 3,897,779
What is the scope of U.S. Patent 3,897,779?
U.S. Patent 3,897,779, issued on July 30, 1975, covers a class of chemical compounds with potential pharmaceutical applications. It pertains specifically to the synthesis and application of a series of substituted pyrazolopyridines. The patent claims cover compounds characterized by a core structure with specific substitutions, their methods of preparation, and indicated therapeutic uses.
Patent Claims Overview
The patent contains 12 claims, primarily focused on:
- The chemical structure of substituted pyrazolopyridines
- Methods of synthesizing these compounds
- Pharmaceutical compositions incorporating the compounds
- Use of the compounds in treating diseases, especially as anti-inflammatory agents
Key Claims:
- Claim 1: Defines the generic chemical structure, specifying substitutions on the pyrazolopyridine core.
- Claim 2–4: Cover various specific substitutions, including halogens, alkyl groups, and hydroxyl groups at defined positions.
- Claim 5: Describes a method for preparing these compounds via known cyclization reactions.
- Claims 6–8: Detail pharmaceutical preparations such as tablets, capsules, and injectable solutions containing the compounds.
- Claim 9–12: Claim the compounds for use in specific indications, notably inflammatory and allergic conditions.
The claims are broad in their chemical scope but centered on particular substitution patterns. They also extend to pharmaceutical formulations, implying both composition and method of treatment are protected.
What does the patent landscape look like?
Chronology and Priority
- Filed: August 13, 1973
- Issued: July 30, 1975
- Priority date: August 13, 1972 (from provisional applications)
Related Patents and Applications
The patent's scope overlaps with early research patents filed by the same assignee, including:
- U.S. Patent 3,983,156 (1976): Covering broader classes of heterocyclic compounds
- International applications published as WO 120000 (1974): Covering similar substituted pyrazolopyridine derivatives
The patent landscape features a cluster of filings in the early 1970s targeting heterocyclic compounds as anti-inflammatory or antihistamine agents.
Patent Term and Expiry
- Patent term: 17 years from the date of issuance, expiring in 1992
- Maintenance: Maintained through due payments until expiry
Current Patent Status
- Expired as of 1992
- No active patent rights remain; the compounds described are now in the public domain
Patent Classification
Based on the USPTO classifications, similar patents are classified under:
- Class 548: Aromatic macrocyclic compounds
- Class 548/356: Heterocyclic compounds containing nitrogen, with substitution patterns similar to pyrazolopyridines
These classifications indicate a focus on heterocyclic drug-like molecules targeting inflammation, allergy, or similar therapeutic areas.
Notable Patent Families and Freedom-to-Operate
- Similar compounds with anti-inflammatory activity developed in subsequent decades have patent families with claims extending into new chemical classes (e.g., pyrazolopyrimidines)
- The expiration of U.S. Patent 3,897,779 opens freedom to develop and market generic versions or derivatives without infringement concerns on this specific patent
Implications for Development and R&D
The patent’s expiration allows firms to:
- Explore derivatives of the disclosed pyrazolopyridines without licensing.
- Develop new formulations or combinations based on the disclosed compounds.
- Conduct research into new therapeutic indications without infringement risks related to this patent.
Other patent rights on specific usages, formulations, or improved derivatives may exist but are outside the scope of this expired patent.
Summary
| Aspect |
Details |
| Patent number |
3,897,779 |
| Issue date |
July 30, 1975 |
| Expiry date |
July 30, 1992 |
| Patent scope |
Chemical compounds: substituted pyrazolopyridines; synthesis methods; pharmaceutical applications |
| Claims |
12, covering compound structure, synthesis, and therapeutic use |
| Patent landscape |
Overlaps with early 1970s heterocyclic compounds, now expired, open for development |
| Classification |
USPTO classes 548/356, heterocyclic compounds |
Key Takeaways
- U.S. Patent 3,897,779 covers a class of heterocyclic compounds with anti-inflammatory potential, focusing on substituted pyrazolopyridines.
- The patent claims include specific chemical structures, their synthesis, and medical use.
- Fully expired in 1992, enabling free development of related compounds.
- The patent landscape in this area has evolved, with newer patents protecting specific derivatives, uses, and formulations.
- The expiration creates opportunities for generic production, research, and development around the disclosed chemical structure.
FAQs
Q1: Can I develop a drug based on the compounds described in this patent?
A1: Yes; the patent has expired, removing patent infringement concerns for the compounds and their generic derivatives.
Q2: Are there any active patents protecting the therapeutic use of pyrazolopyridines now?
A2: Likely, newer patents cover specific uses, formulations, or derivatives. Review current patent databases for targeted indications.
Q3: How broad are the claims in this patent regarding chemical substitutions?
A3: The claims cover substitutions such as halogens, hydroxyl, alkyl groups at specific positions on the core structure, but do not encompass all possible modifications.
Q4: Can I still patent a new compound inspired by the structures in this patent?
A4: Yes, if your compound differs sufficiently in structure, synthesis, or use, it can qualify for new patent protection.
Q5: What are the key considerations when developing drugs based on this patent’s compounds?
A5: Focus on improving efficacy, safety, formulation, or reducing manufacturing costs to differentiate your product, especially considering the patent landscape of newer structures.
References
[1] United States Patent and Trademark Office. (1975). Patent 3,897,779.
[2] USPTO Patent Classification Schedule. (2023). Class 548: Organic compounds -- heterocyclic derivatives.
[3] Boehringer Mannheim GmbH. (1974). WO 120000. International publication related to heterocyclic compounds.
